Side effects are evaluated through clinical trials and post-marketing surveillance. During clinical trials, drugs are tested in controlled environments to identify common side effects. However, some side effects may only become apparent after a drug is used by a larger, more diverse population in real-world settings. Pharmacovigilance programs play a critical role in monitoring, assessing, and managing side effects once a drug is on the market.
